Wee1 inhibitor MK1775 sensitizes KRAS mutated NSCLC cells to sorafenib

E. Caiola, R. Frapolli, M. Tomanelli, R. Valerio, A. Iezzi, M.C. Garassino, M. Broggini, M. Marabese

Research output: Contribution to journalArticle

Cite this